Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

PR Newswire News

2021-09-18
16:13:00
Xinhua Silk Road: Annual report on image of Suzhou city released to better tell Suzhou stories during 2021 AI Expo Thu.
08:00:00
Innovent Releases Interim Analysis Results of Sintilimab plus Chemotherapy for the First-Line Treatment of Esophageal Squamous Cell Carcinoma in the Phase 3 ORIENT-15 Study at ESMO Congress 2021
08:00:00
Innovent Releases Interim Analysis Results of Sintilimab in Combination with Chemotherapy for the First-Line Treatment of Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma in the Phase 3 ORIENT-16 Study at ESMO Congress 2021
04:53:00
SARS-CoV-2, Influenza A inactivated by zinc-embedded nylon fabric
2021-09-17
22:05:00
Zoomlion Breaks Yet Another Record for High-End Manufacturing, Exports China's Largest Tonnage Crawler Crane
21:28:00
ZTE wins largest share in bid section 4 of China Mobile's high-end router centralized procurement
21:19:00
Hysan Development Acquires Premium Commercial Project in Jing'an District for RMB3.5 billion
20:40:00
#WeToo launches movement to bring leading businesses and individuals into the fight against child abuse
20:00:00
The NDA of Henlius Novel Anti-PD-1 mAb Serplulimab for First-Line Treatment of sqNSCLC Accepted by China's NMPA, Phase 3 MRCT Met its Primary Endpoint
20:00:00
InnoCare and Keymed Jointly Announce Approval of Clinical Trial of CD20xCD3 Bispecific Antibody CM355
19:00:00
Global Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 7, 2021
15:26:00
Right Issue to Develop Ultra-Micro Ecosystem, A New Source of Growth Amidst the Pandemic
13:24:00
The Way to Best LCOE (IV)
09:05:00
"Dubbing Academy" Completed Successfully Helping Youths in Realising Dreams
08:36:00
Red ginseng selected as the most popular Chuseok (Korean Thanksgiving day) gift in Korea
08:00:00
Innovent Releases Phase 2 Results of Pemigatinib in Chinese Patients with Advanced Cholangiocarcinoma at ESMO Congress 2021
08:00:00
CStone will present registrational clinical study data of Sugemalimab in patients with stage III non-small cell lung cancer in an oral presentation at ESMO Congress 2021
06:30:00
Everest Medicines, Sinovent and SinoMab Announce Licensing Agreement for Global Development, Manufacturing and Commercialization of Novel BTK Inhibitor in Renal Diseases
05:37:00
Nils Andersen-Röed joins Binance from Europol to further strengthen investigations and audit team
03:59:00
PharmaZell and Novasep enter into exclusive negotiations in new drive to create a technology-driven leader for complex small molecules and ADCs of global scale
Back to Top